However, this popular belief is largely based on misconceptions
4 There is a growing movement among patients, healthcare providers, insurance providers and broader society to recognise obesity as a chronic and progressive disease that is affected by multiple medical and psychosocial issues
PMID 15950558
Common injection sites include the abdomen, upper thigh, and upper arm
Hanmi Pharmaceutical, the core operating company of Hanmi Science, announced on Wednesday that it has signed an exclusive distribution agreement with Mexican pharmaceutical company Laboratorios Sanfer for its GLP-1 obesity drug efpeglenatide and its Dapalon-lineup diabetes treatment combination products
Pros: One-time treatment Long-term weight loss supported by decades of research Often improves diabetes, blood pressure, and sleep apnea No lifelong medication costs Cons: Requires surgery and recovery Lifestyle changes are necessary For many patients with severe obesity, bariatric surgery remains the most effective long-term treatment available